Cargando…
Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
Background: High mobility group box (HMGB) proteins are DNA chaperones involved in transcription, DNA repair, and genome stability. Extracellular HMGBs also act as cytokines to promote inflammatory and immune responses. Accumulating evidence has suggested that HMGBs are implicated in cancer pathogen...
Autores principales: | Lin, Tong, Zhang, Yingzhao, Lin, Zhimei, Peng, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585836/ https://www.ncbi.nlm.nih.gov/pubmed/34777483 http://dx.doi.org/10.3389/fgene.2021.764245 |
Ejemplares similares
-
A Pan-Cancer Analysis of the Oncogenic Role of BCL7B: A Potential Biomarker for Prognosis and Immunotherapy
por: Yang, Dinglong, et al.
Publicado: (2022) -
ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
por: Lin, Tong, et al.
Publicado: (2021) -
Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023) -
Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022) -
Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
por: Wang, Yuhang, et al.
Publicado: (2023)